- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CORDLIFE GROUP Aktie jetzt für 0€ handeln | |||||
| 04.12. | Cordlife faces $5.45m in claims over 109 damaged cord blood units | 2 | Singapore Business Review | ||
| 02.12. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON CLAIMS AGAINST THE COMPANY | 2 | SGX Company Announcements | ||
| 02.12. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 02.12. | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF APPOINTMENT::APPOINTMENT OF NON-INDEPENDENT NON-EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 01.12. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::REGULATORY UPDATE: RECEIPT OF NOTICE OF REGULATORY ACTION | 2 | SGX Company Announcements | ||
| 01.12. | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 4 | SGX Company Announcements | ||
| 27.11. | Health ministry suspends Cordlife's blood banking license | 3 | Singapore Business Review | ||
| 27.11. | CORDLIFE GROUP LIMITED: REQUEST FOR TRADING HALT::REQUEST FOR TRADING HALT | 2 | SGX Company Announcements | ||
| 14.11. | CORDLIFE GROUP LIMITED: REPL::FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 2 | SGX Company Announcements | ||
| 14.11. | CORDLIFE GROUP LIMITED: FINANCIAL STATEMENTS AND RELATED ANNOUNCEMENT::THIRD QUARTER RESULTS | 1 | SGX Company Announcements | ||
| 30.10. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CHANGES TO THE COMPOSITION OF THE BOARD AND BOARD COMMITTEES | 1 | SGX Company Announcements | ||
| 30.10. | CORDLIFE GROUP LIMITED: CHANGE - ANNOUNCEMENT OF CESSATION::CESSATION OF EXECUTIVE CHAIRMAN | 1 | SGX Company Announcements | ||
| 27.10. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::SUBMISSION OF WRITTEN REPRESENTATIONS TO MOH | 2 | SGX Company Announcements | ||
| 21.10. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::CLARIFICATION TO CERTAIN MEDIA REPORTS | 1 | SGX Company Announcements | ||
| 13.10. | Cordlife granted extension to appeal license suspension | 2 | Singapore Business Review | ||
| 13.10. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::EXTENSION OF TIME GRANTED BY MOH TO PROVIDE WRITTEN REPRESENTATIONS | 1 | SGX Company Announcements | ||
| 07.10. | Cordlife assures continuity of operations amidst possible licence suspension | 7 | Singapore Business Review | ||
| 06.10. | CORDLIFE GROUP LIMITED: GENERAL ANNOUNCEMENT::UPDATE ON GOING CONCERN ASSESSMENT | 1 | SGX Company Announcements | ||
| 02.10. | Cordlife to assess 'going concern' viability amidst potential suspension | 5 | Singapore Business Review | ||
| 01.10. | CORDLIFE GROUP LIMITED: REQUEST FOR LIFTING OF TRADING HALT::REQUEST FOR LIFTING OF TRADING HALT | 1 | SGX Company Announcements |
1 2 3 Weiter >>
41 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| Q&M DENTAL | 0,200 | -1,96 % | Q & M DENTAL GROUP (SINGAPORE) LIMITED: DISCLOSURE OF INTEREST/CHANGES IN INTEREST OF DIRECTOR/CHIEF EXECUTIVE OFFICER::DISCLOSURE OF CHANGES IN INTEREST OF DIRECTOR AND CHIEF EXECUTIVE OFFICER - DR. NG CHIN SIAU | ||
| SDI LIMITED | - | - | SDI Ltd meldet Umsatzwachstum für das erste Halbjahr 2025 | ||
| SIEMENS HEALTHINEERS | 44,640 | +0,97 % | Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers | DJ Moody's vergibt Investmentgrade-Rating "A3" an Siemens Healthineers
DOW JONES--Moody's hat Siemens Healthineers die Bonitätsbewertung A3 gegeben, was als sichere Anlage gilt. Der Ausblick ist... ► Artikel lesen | |
| FRESENIUS | 47,780 | +0,74 % | JPMORGAN stuft Fresenius SE auf 'Overweight' | NEW YORK (dpa-AFX Analyser) - Die US-Bank JPMorgan hat die Einstufung für Fresenius mit einem Kursziel von 53,60 Euro auf "Overweight" belassen. Die Veranstaltung mit dem Biopharma-Management der Bad... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 40,300 | +0,30 % | Fresenius Medical Care ernennt neuen Chief Medical Officer | DJ Fresenius Medical Care ernennt neuen Chief Medical Officer
DOW JONES--Fresenius Medical Care bekommt einen neuen Chief Medical Officer. Wie der Dialysespezialist mitteilte, hat er Charles Hugh-Jones... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 35,580 | -2,37 % | BrightSpring upgraded at KeyBanc on specialty pharmacy and EBITDA prospects | ||
| HEARTBEAM | 3,060 | -11,30 % | Heartbeam stock is a buy, this analyst says | ||
| PROGYNY | 26,000 | -0,12 % | Progyny, Inc. - 8-K, Current Report | ||
| CARL ZEISS MEDITEC | 40,000 | +0,15 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Carl Zeiss Meditec mit einem Kursziel von 53 Euro auf "Neutral" belassen. Die Suche nach einem neuen Chef laufe, aber werde... ► Artikel lesen | |
| ALIGNMENT HEALTHCARE | 20,560 | +2,65 % | Alignment Healthcare Reports Third Quarter 2025 Results, Surpasses High-End of Guidance Across All Key Metrics | Reports Q3 revenue of $993.7 million, up 43.5% year-over-yearBeats high end of third quarter guidance and raises full-year outlook across all key metrics: membership, revenue, adjusted gross profit... ► Artikel lesen | |
| GERRESHEIMER | 26,880 | -0,67 % | UBS stuft GERRESHEIMER AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Gerresheimer nach einem "Report" eines Leerverkäufers mit einem Kursziel von 29 Euro auf "Neutral" belassen. Er habe bereits... ► Artikel lesen | |
| BETA BIONICS | 29,150 | -1,62 % | Beta Bionics, Inc.: Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance | IRVINE, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today reported its financial... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 33,770 | -5,27 % | UBS stuft Procept BioRobotics mit "Buy" ein - Wachstum bei Systemauslastung als Treiber | ||
| GENEDX | 135,46 | -4,40 % | GeneDx and Guardant Health named as BTIG's top picks for 2026 | ||
| RXSIGHT | 12,620 | -1,33 % | Pre-market Movers: Basel Medical Group, SOBR Safe, ProKidney, RxSight, Mustang Bio | OTTAWA (dpa-AFX) - The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 08.05 A.M. ET).In the Green Basel Medical Group Ltd (BMGL) is up over 88% at... ► Artikel lesen |
Das Unternehmen CORDLIFE GROUP LIMITED kann der Branche Gesundheitswesen zugeordnet werden.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CORDLIFE GROUP LIMITED finden Sie auf Wallstreet Online.